Article
Inactivation of SSI-1, a JAK/STAT inhibitor, in human hepatocellular carcinomas, as revealed by two-dimensional electrophoresis.
Journal of hepatology - 1 Mar 2001
Nagai H, Kim Y S, Lee K T, Chu M Y, Konishi N, Fujimoto J, Baba M, Matsubara K, Emi M
Abstract excerpt
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is one of the most common human cancers, and many efforts have been paid to discover aberrant expression control in HCC, however the specific molecular mechanisms involved in hepatocarcinogenesis remain to be determined. METHODS: To investigate genomic changes that occur in human primary hepatocellular carcinomas (HCC), we carried out restriction landmark genomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.